153 related articles for article (PubMed ID: 28261881)
1. Alterations in microRNA expression profiles in inflamed and noninflamed ascending colon mucosae of patients with active Crohn's disease.
Wu LY; Ma XP; Shi Y; Bao CH; Jin XM; Lu Y; Zhao JM; Zhou CL; Chen D; Liu HR
J Gastroenterol Hepatol; 2017 Oct; 32(10):1706-1715. PubMed ID: 28261881
[TBL] [Abstract][Full Text] [Related]
2. Altered microRNA expression in inflamed and non-inflamed terminal ileal mucosa of adult patients with active Crohn's disease.
Guo Z; Wu R; Gong J; Zhu W; Li Y; Wang Z; Li N; Li J
J Gastroenterol Hepatol; 2015 Jan; 30(1):109-16. PubMed ID: 24910152
[TBL] [Abstract][Full Text] [Related]
3. Integrated miRNA and mRNA expression profiling in inflamed colon of patients with ulcerative colitis.
Van der Goten J; Vanhove W; Lemaire K; Van Lommel L; Machiels K; Wollants WJ; De Preter V; De Hertogh G; Ferrante M; Van Assche G; Rutgeerts P; Schuit F; Vermeire S; Arijs I
PLoS One; 2014; 9(12):e116117. PubMed ID: 25546151
[TBL] [Abstract][Full Text] [Related]
4. Identification of microRNAs associated with ileal and colonic Crohn's disease.
Wu F; Zhang S; Dassopoulos T; Harris ML; Bayless TM; Meltzer SJ; Brant SR; Kwon JH
Inflamm Bowel Dis; 2010 Oct; 16(10):1729-38. PubMed ID: 20848482
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.
Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR
BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994
[TBL] [Abstract][Full Text] [Related]
6. Functional Implications of MicroRNAs in Crohn's Disease Revealed by Integrating MicroRNA and Messenger RNA Expression Profiling.
Palmieri O; Creanza TM; Bossa F; Latiano T; Corritore G; Palumbo O; Martino G; Biscaglia G; Scimeca D; Carella M; Ancona N; Andriulli A; Latiano A
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28726756
[TBL] [Abstract][Full Text] [Related]
7. RNA-seq Reveals Transcriptomic Differences in Inflamed and Noninflamed Intestinal Mucosa of Crohn's Disease Patients Compared with Normal Mucosa of Healthy Controls.
Hong SN; Joung JG; Bae JS; Lee CS; Koo JS; Park SJ; Im JP; Kim YS; Kim JW; Park WY; Kim YH
Inflamm Bowel Dis; 2017 Jul; 23(7):1098-1108. PubMed ID: 28613228
[TBL] [Abstract][Full Text] [Related]
8. Mucosal MicroRNAs Expression Profiles before and after Exclusive Enteral Nutrition Therapy in Adult Patients with Crohn's Disease.
Guo Z; Gong J; Li Y; Gu L; Cao L; Wang Z; Zhu W; Li J
Nutrients; 2016 Aug; 8(8):. PubMed ID: 27556489
[TBL] [Abstract][Full Text] [Related]
9. Differential miRNA Expression in Ileal and Colonic Tissues Reveals an Altered Immunoregulatory Molecular Profile in Individuals With Crohn's Disease versus Healthy Subjects.
Mohammadi A; Kelly OB; Smith MI; Kabakchiev B; Silverberg MS
J Crohns Colitis; 2019 Oct; 13(11):1459-1469. PubMed ID: 31001642
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-124 Promotes Intestinal Inflammation by Targeting Aryl Hydrocarbon Receptor in Crohn's Disease.
Zhao Y; Ma T; Chen W; Chen Y; Li M; Ren L; Chen J; Cao R; Feng Y; Zhang H; Shi R
J Crohns Colitis; 2016 Jun; 10(6):703-12. PubMed ID: 26802080
[TBL] [Abstract][Full Text] [Related]
11. Peripheral blood microRNAs distinguish active ulcerative colitis and Crohn's disease.
Wu F; Guo NJ; Tian H; Marohn M; Gearhart S; Bayless TM; Brant SR; Kwon JH
Inflamm Bowel Dis; 2011 Jan; 17(1):241-50. PubMed ID: 20812331
[TBL] [Abstract][Full Text] [Related]
12. Characterization of intestinal gene expression profiles in Crohn's disease by genome-wide microarray analysis.
Noble CL; Abbas AR; Lees CW; Cornelius J; Toy K; Modrusan Z; Clark HF; Arnott ID; Penman ID; Satsangi J; Diehl L
Inflamm Bowel Dis; 2010 Oct; 16(10):1717-28. PubMed ID: 20848455
[TBL] [Abstract][Full Text] [Related]
13. Increased duodenal expression of miR-146a and -155 in pediatric Crohn's disease.
Szűcs D; Béres NJ; Rokonay R; Boros K; Borka K; Kiss Z; Arató A; Szabó AJ; Vannay Á; Sziksz E; Bereczki C; Veres G
World J Gastroenterol; 2016 Jul; 22(26):6027-35. PubMed ID: 27468194
[TBL] [Abstract][Full Text] [Related]
14. Circulating microRNAs as biomarkers of adult Crohn's disease.
Jensen MD; Andersen RF; Christensen H; Nathan T; Kjeldsen J; Madsen JS
Eur J Gastroenterol Hepatol; 2015 Sep; 27(9):1038-44. PubMed ID: 26230660
[TBL] [Abstract][Full Text] [Related]
15. miR-19b downregulates intestinal SOCS3 to reduce intestinal inflammation in Crohn's disease.
Cheng X; Zhang X; Su J; Zhang Y; Zhou W; Zhou J; Wang C; Liang H; Chen X; Shi R; Zen K; Zhang CY; Zhang H
Sci Rep; 2015 May; 5():10397. PubMed ID: 25997679
[TBL] [Abstract][Full Text] [Related]
16. Identification of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease.
Fasseu M; Tréton X; Guichard C; Pedruzzi E; Cazals-Hatem D; Richard C; Aparicio T; Daniel F; Soulé JC; Moreau R; Bouhnik Y; Laburthe M; Groyer A; Ogier-Denis E
PLoS One; 2010 Oct; 5(10):. PubMed ID: 20957151
[TBL] [Abstract][Full Text] [Related]
17. miR-141 Regulates colonic leukocytic trafficking by targeting CXCL12β during murine colitis and human Crohn's disease.
Huang Z; Shi T; Zhou Q; Shi S; Zhao R; Shi H; Dong L; Zhang C; Zeng K; Chen J; Zhang J
Gut; 2014 Aug; 63(8):1247-57. PubMed ID: 24000293
[TBL] [Abstract][Full Text] [Related]
18. Expression alteration of long non-coding RNAs and their target genes in the intestinal mucosa of patients with Crohn's disease.
Li N; Shi R
Clin Chim Acta; 2019 Jul; 494():14-21. PubMed ID: 30862513
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-143 Targets ATG2B to Inhibit Autophagy and Increase Inflammatory Responses in Crohn's Disease.
Lin XT; Zheng XB; Fan DJ; Yao QQ; Hu JC; Lian L; Wu XJ; Lan P; He XS
Inflamm Bowel Dis; 2018 Mar; 24(4):781-791. PubMed ID: 29562274
[TBL] [Abstract][Full Text] [Related]
20. Identification of serum and tissue micro-RNA expression profiles in different stages of inflammatory bowel disease.
Iborra M; Bernuzzi F; Correale C; Vetrano S; Fiorino G; Beltrán B; Marabita F; Locati M; Spinelli A; Nos P; Invernizzi P; Danese S
Clin Exp Immunol; 2013 Aug; 173(2):250-8. PubMed ID: 23607522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
